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Abstract
Background:  Most retained introns found in human cDNAs generated by high-throughput
sequencing projects seem to result from underspliced transcripts, and thus they capture
intermediate steps of pre-mRNA splicing. On the other hand, mutations in splice sites cause exon
skipping of the respective exon or activation of pre-existing cryptic sites. Both types of events
reflect properties of the splicing mechanism.
Results: The retained introns were significantly shorter than constitutive ones, and skipped exons
are shorter than exons with cryptic sites. Both donor and acceptor splice sites of retained introns
were weaker than splice sites of constitutive introns. The authentic acceptor sites affected by
mutations were significantly weaker in exons with activated cryptic sites than in skipped exons. The
distance from a mutated splice site to the nearest equivalent site is significantly shorter in cases of
activated cryptic sites compared to exon skipping events. The prevalence of retained introns within
genes monotonically increased in the 5'-to-3' direction (more retained introns close to the 3'-end),
consistent with the model of co-transcriptional splicing. The density of exonic splicing enhancers
was higher, and the density of exonic splicing silencers lower in retained introns compared to
constitutive ones and in exons with cryptic sites compared to skipped exons.
Conclusion:  Thus the analysis of retained introns in human cDNA, exons skipped due to
mutations in splice sites and exons with cryptic sites produced results consistent with the intron
definition mechanism of splicing of short introns, co-transcriptional splicing, dependence of splicing
efficiency on the splice site strength and the density of candidate exonic splicing enhancers and
silencers. These results are consistent with other, recently published analyses.
Background
Vertebrate genes consist of relatively short exons separated
by considerably larger introns. The introns of lower
eukaryotes, invertebrates and plants are much shorter.
This difference may be explained by the preference for two
possible mechanisms for recognition of the exon-intron
boundaries by the splicing machinery. In the case of long
introns, the exon definition mechanism initially recog-
nizes pairs of splicing sites corresponding to one exon.
Vice versa, short introns are recognized by the intron def-
inition that pairs splicing sites across introns [1]. Histori-
cally, the intron definition mechanism seems to be the
ancestral one, whereas exon definition likely is a relatively
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recent innovation that, in particular, created the possibil-
ity of regulated alternative splicing [2].
These models yield different consequences of mutations
that destroy splicing sites. Errors in exon definition should
lead to exon skipping or, if there are strong cryptic sites,
the use of the latter, whereas errors in intron definition
should cause intron retention. Indeed, exactly this behav-
ior was observed in vivo and in vitro experiments
(reviewed by [1]), and in early analyses of disease-causing
mutations of human genes [3,4]. These predictions also
agree to the distribution of alternative splicing types in
different organisms. In vertebrates, where long introns are
frequent, the prevalent type of alternative splicing is exon
skipping [5,6], while in plants, where the majority of
introns are short, the most frequent type is intron reten-
tion [5,7].
Intron retention is the least studied type of alternative and
aberrant splicing. In contrast with other types of alterna-
tive splicing, which involve the choice between different
splice sites, intron retention represents complete absence
of splicing. Some specific features of retained introns have
become clear in recent studies of human [8,9] and plant
transcriptomes [10]. Retained introns were found to differ
from other introns in GC content, that was lower than in
exons but higher than in constitutively spliced out
introns. Retained introns were shown to be shorter on the
average than constitutively spliced out ones and exhibited
a tendency to occur in 5'- and 3'-untranslated regions [8-
10]; they also have weaker sites [9].
In several cases intron retention clearly has a function. A
considerable fraction of retained introns encode identifia-
ble protein domains or parts thereof [8,11]. In some cases
intron retention produces different functional isoforms
(EBNA-3 family anigens of the Epstein-Barr virus [12]);
isoforms with aberrant function (cancerspecific form of
cholecystokinin 2 receptor [13]); truncated proteins that
may be involved in regulation (cold-dependent lipid
metabolism in plants [14], nuclear transport of retrovi-
ruses [15], autoregulation of splicing [16]); non-func-
tional proteins (P-element of Drosophila [17] or rat
cytochrome P450 CYP2C11 in stressed liver [18]); pro-
teins with unknown function (serine protease kallikrein
[19,20]); or, finally, isoforms with no known functional
differences between the variants (hormone urocortin 1
prepropeptide [21], cyclooxygenase [22], D1 dopamine
receptor (DR1) interacting protein calcyon [23], mouse
homeodomain transcription factor Tgif2  [24]). At that,
intron retention may be conserved in vertebrates, e.g.
intron 3 of splicing regulator of the SR family 9G8 [16] or
species-specific, e.g. intron 2 of Tgif2, present in the
mouse gene, but not its human ortholog Tgif2 [24].
However, it is likely that many cases of observed intron
retention were caused by errors of the splicing machinery.
Retained introns are the least conserved type of elemen-
tary alternatives [25]. Moreover, large scale projects that
aim at sequencing of full-length cDNA use normalization
procedures to enrich low copy transcripts, and these pro-
cedures seem to increase the fraction of underspliced tran-
scripts that retain one or several introns [26,27].
Traditionally such artifacts in cDNA databases were
treated as a nuisance and filtered out in attempts to create
"clean" sets of alternative isoforms. We tried to look at
introns retained in human cDNA data from another
angle, assuming that they capture intermediate states of
the splicing process and thus provide a glimpse on the
splicing mechanisms.
Another way to look at this mechanism is to analyze con-
sequences of mutations in splice sites. This also has been
the subject of several very recent studies. Such mutations
have two major possible outcomes: exon skipping and
activation of cryptic sites, whereas intron retention is rela-
tively rare [3,28-30]. One of important determinants of
the cryptic donor splice site phenotype is the presence of
a strong candidate donor splice site in the vicinity of
mutated sites [3,31]. Cryptic acceptor splice sites are more
frequent in exons than in introns, likely due to depletion
of AG dinucleotides upstream of the original acceptor
sites [32]. There are differences in the distribution of can-
didate exonic enhancers and silencers between skipped
exons and exons with activated cryptic sites [33].
Here we systematically studied aberrant and mutated
splicing. Specifically, we compared lengths of affected and
adjacent introns and exons, as well strengths of splice sites
and distribution of predicted splicing enhancers and
silencers in these and adjacent exons and introns. While
confirming many earlier predictions, our study also pro-
vides a number of new observations that are largely con-
sistent with existing models of the splicing mechanisms.
Results
Comparison of retained and constitutive introns
Sets of retained (Fig. 1) and constitutive (constitutively
spliced out) introns were constructed as described in Data
and Methods and compared with the aim to identify pos-
sible determinants of intron retention. We considered the
distribution of intron lengths and of lengths of the flank-
ing exons, scores of intron splice sites and the distal sites
in the flanking exons (the acceptor site of the upstream
exon and the donor site of the downstream exon), densi-
ties of exonic cis-acting elements, intron positions within
the gene. The results are summarized in Table 1.
The distributions of the intron lengths of retained and
constitutive introns were significantly different (Fig. 2,BMC Genomics 2008, 9:13 http://www.biomedcentral.com/1471-2164/9/13
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Two-sample Kolmogorov-Smirnov test P < 10-15). The
retained introns tend to be shorter than constitutively
spliced out ones: 84% of the retained introns were shorter
than 1000 nucleotides, compared to only 40% of the con-
stitutive introns. The median size of the retained introns
was 337, whereas the median size of the constitutive
introns was 1481 nucleotides. No significant differences
between distributions of flanking exons lengths were
observed (data not shown).
Scores of the intron splice sites and splice sites of the
flanking exons for retained and constitutively spliced
introns were calculated using a positional weight matrix
as described in Data and Methods. Splice sites of retained
introns were weaker: the distributions of the splice sites
scores for the retained and constitutive introns were sig-
nificantly different for both acceptor and donor sites
(Two-sample Kolmogorov-Smirnov test P < 10-15). The
median scores for the donor sites of the retained and con-
stitutive introns were 18.2 and 18.8 respectively, whereas
for the acceptor sites they were 18.03 and 19.06 respec-
tively.
The donor site scores of the 3'-flanking (downstream)
exons were similar for the retained and constitutive
introns, whereas the acceptor sites of the 5'-flanking
(upstream) exons were considerable weaker for the
retained introns compared to the constitutive ones, with
medians 18.6 and 19.1, respectively (Two-sample Kol-
mogorov-Smirnov test P < 10-10).
Densities of cis-acting elements of both types of introns
were calculated using three available programs, ESEfinder
[34], RESCUE-ESE [35], and PESX [36,37], as described in
Data and Methods. The results are described in Table 1.
The densities of most types of predicted exonic splicing
enhancers (ESEs) were higher in the retained introns,
whereas the density of exonic splicing silencers (ESSs) was
higher in the constitutive introns (Fig. 3, 4).
Definition of scored intron retention events Figure 1
Definition of scored intron retention events. Gray rec-
tangles represent exons of the RefSeq gene and mRNA. 
Exon/intron boundaries are marked by dotted lines.
RefSeq gene
mRNA 
retained intron
Table 1: Properties of retained and constitutive introns. For all intron parameters the medians are reported. The last two columns 
report the statistical significance of the differences of the distributions by the Kolmogorov-Smirnov test (KS) and Student's t-test (ST); 
n/s – non significant.
introns
Retained Constitutively spliced KS ST
Set size 1197 137580
Intron length (nucleotides) 337 1481 <10-15 <10-15
Splice site scores
Acceptor site of the of 5'-exon 18,60 19,09 <10-15 <10-11
Donor site 18,17 18,80 <10-15 <10-15
Acceptor 18,03 19,06 <10-15 <10-15
Donor site of 3'-exon 18,74 18,79 n/s n/s
Cis-acting elements (candidate sites per nucleotie)
ESEfinder: SC35 0,046 0,034 <10-15 <10-15
ESEfinder: SF2/ASF 0,040 0,028 <10-15 <10-15
ESEfinder: SRp40 0,041 0,038 <10-15
ESEfinder: SRp55 0,022 0,022 <10-15 n/s
RESCUE-ESE 0,050 0,068 <10-15 <10-15
PESE 0,043 0,035 <10-15 <10-15
PESS 0,013 0,048 <10-15 <10-15
Relative position
by ordinal number 0,6 0,5 <10-15*< 1 0 -15
by gene 0,671 0,597 <10-9 <10-15
by mRNA 0,446 0,354 <10-15 <10-15
by mRNA w/o last exon 0,688 0,575 <10-15 <10-15
* Chi-square testBMC Genomics 2008, 9:13 http://www.biomedcentral.com/1471-2164/9/13
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At that, the average densities of all four ESEfinder motifs
were higher in the retained introns (Fig. 3). The maximal
difference between the median densities were observed
for the SF2/ASF sites (median densities 0.040 and 0.028
for the retained and constitutive introns, respectively),
whereas the lowest difference was observed for the SRp55
sites (median densities 0.0217 and 0.0215, non-signifi-
cant). The density of PESE octamers (enhancers) was also
higher in the retained introns (Fig. 4), whereas the density
of PESS octamers (silencers) was higher in the constitutive
introns (Fig. 4). In contrast, the density of ESE hexamers
predicted by RESCUE-ESE was significantly higher in the
constitutively splice introns than in the retained ones (Fig.
4). All these differences were statistically significant (Two-
sample Kolmogorov-Smirnov test P < 10-15).
The relative position of an intron in a gene was defined as
the ratio RP = D/L, where D was the distance from the
gene 5'-end to the intron 5'-end (the donor site), and L
was the gene length (the distance between 5'- and 3'-ends,
as listed in RefSeq). Since terminal exons and introns may
have considerably different lengths ([38], and data not
shown), the distances were calculated in several different
settings. Firstly, we used unspliced genes, as annotated in
RefSeq, and in this cases the distances were calculated
using the genomic sequence. Secondly, we considered
spliced genes: all introns were removed and the studied
intron was reduced to a single point, "intron shadow",
and the distances were calculated using the mRNA
sequence. Thirdly, we considered spliced genes with the
last exon removed as well. Finally, we defined relative
position of an intron as its ordinal number divided by the
total number of introns in a gene.
The constitutive introns (blue bars in Fig. 5) are shifted
towards the 3'-end in the unspliced gene calculations (Fig.
Histograms of ESE densities predicted by ESEfinder Figure 3
Histograms of ESE densities predicted by ESEfinder. Red: retained introns; blue: constitutive introns.
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Histograms of intron lengths Figure 2
Histograms of intron lengths. Red: retained introns; blue: 
constitutive introns.
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5b), and towards 5'-ends in spliced gene calculations (Fig.
5c). This is consistent with decreasing intron density and
increasing exon length in the 5'-to-3' direction [38].
Indeed, when the last 3'terminal intron is removed, the
distribution becomes almost uniform (Fig. 5d).
The situation with retained introns is dramatically differ-
ent (Two-sample Kolmogorov-Smirnov test P < 10-15 for
relative intron positions in case with spliced genes and
spliced genes with the last exon removed, and P < 10-9 for
unspliced genes; the χ2-test P < 10-15 for the ordinal intron
number). The distribution of the retained introns (red
bars in Fig. 5) is considerably shifted towards the 3' in all
settings, as compared to the constitutive introns. Accord-
ingly, the fraction of retained introns increases in the 5'-
to-3' direction, leveling off at about middle of the gene
(the orange curve in Fig. 5).
Comparison of skipped and cryptic-site exons
The sets of splice-site inactivating mutations were col-
lected as described in Data and Methods. Only mutations
directly in the donor and acceptor sites were considered.
The exons affected by the mutations were divided into
skipped exons (S-exons) and exons utilizing cryptic sites
(C-exons). The donor and acceptor site mutations were
considered both separately and jointly, to increase the sta-
tistical power of the observations. The results are summa-
rized in Table 2.
The S-exons were found to be significantly shorter than
the C-exons (median sizes 114 and 136). No significant
differences were observed in the lengths of flanking
introns (data not shown).
Scores of authentic splice sites and all splice sites in the
adjacent exons and introns for the S- and C-exons were
calculated as described in Data and Methods. Unexpect-
edly, the authentic acceptor sites affected by mutations
were significantly weaker in the C-exons than in the S-
exons, with the median scores 18.72 and 19.59, respec-
tively (the Mann-Witney test P = 0.05). No significant dif-
ferences were observed in the distribution of authentic site
scores in the S- and C-exons with mutated donor sites, nei-
ther in the distribution of scores of all other considered
sites.
The relative enrichment by potential cryptic sites near the
mutated sites was estimated by calculating the distance to
the closest equivalent splice site; the latter were defined as
candidate splice sites of the same type as the authentic site
and having the same or higher splice site score. The search
for equivalent splice sites was limited to the adjacent
intron and exon, and the cases when such sites were
absent were not taken into account in calculations. Both
for the donor and acceptor site mutations, the S- and C-
exons differed dramatically: the equivalent sites were
located much closer to the authentic splice sites of the C-
exons than for the S-exons.
The densities of ESEfinder SF2/ASF and SRp40 motifs, as
well as PESE octamers were significantly higher in the C-
exons than in the S-exons with mutated donor sites,
although the tendency was the same for most other types
of ESEs and also in exons with mutated acceptor sites. The
densities of PESS in exons with mutated splice sites of
both types were higher in the S-exons, but the difference
was not significant even for combined sets (The Kol-
mogorov-Smirnov test P = 0.09).
Histograms of ESE densities predicted by RESCUE-ESE and  PESX/PESE and ESS densities predicted by PESX/PESS Figure 4
Histograms of ESE densities predicted by RESCUE-
ESE and PESX/PESE and ESS densities predicted by 
PESX/PESS. Red: retained introns; blue: constitutive 
introns.
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Discussion
The overall results of this study seem to agree with the
existing biological models. The fact that retained introns
are relatively short is consistent with the possibility that
such introns are spliced out by the intron definition
mechanism, as in this case splicing aberrations should
lead to intron retention. When this study was completed,
similar observations were made also in [9].
The relative weakness of splicing sites in retained introns
and the fact that exons skipped due to mutations of splice
sites do not have strong cryptic sites in the immediate
vicinity shows that the site scores are a reasonable approx-
imation to site strength and may determine their func-
tionality [3,31-33,39,40] At that, unlike [3], the relative
dearth of cryptic candidate sites in the vicinity of the C-
exons was not confined to exclusively to the exons with
mutated donor splice sites. On the other hand, we could
not confirm the observation that strong acceptor sites are
a characteristic of the C-exons with mutated donor sites
[31].
In contrast to previous studies that were primarily inter-
ested in functional (e.g. conserved) alternative splicing of
retained introns [8,10], we did not enforce possible func-
tionality. One of consequences of that is that the majority
of retained introns studied here are unlikely to encode
functional proteins, as only 3.3% of them are frame-pre-
serving (this number is close to 4.6% in-frame retained
introns observed in Arabidopsis [10]). This does not pre-
clude the possible role of such introns in regulation, either
on the protein level (e.g. leading to the synthesis of short-
ened proteins with regulatory function) or on the mRNA
level (leading to NMD-inducing isoforms in some specific
conditions); some examples of such regulatory mecha-
nisms have been mentioned in the Introduction. How-
Histograms of the relative intron positions Figure 5
Histograms of the relative intron positions. A: the relative (ordinal) intron number; B: unspliced genes; C: spliced genes; 
D: spliced genes with the last exon removed (see the text for the detailed explanation). Left axis: the fraction of introns in each 
position bin is given for retained (red) and constitutive (blue) introns separately. Points 0 and 1 on the horizontal axis corre-
spond to the 5'- and 3'-ends of the gene, respectively. Right vertical axis and the orange triangle curve: the fraction of retained 
introns among all introns in the bin.
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ever, both the procedure and the obtained results seem to
indicate that the majority of retained introns in our study
come from underspliced transcripts.
In line with this reasoning, the weakness of sites in
retained introns may have two explanations. The retained
introns might come from underspliced transcripts
(weaker sites imply lower splicing efficiency) or be
instances of regulated alternative splicing. Indeed, func-
Table 2: Properties of skipped exons (S-exons) and exons with cryptic sites (C-exons). For all exon parameters the medians are 
reported. The last column reports parameters of all internal exons in our dataset of RefSeq genes. MW: the statistical significance of 
the differences between the S- and C-exons by the Mann-Witney test; n/s – non significant.
S-exons C-exons MW Internal exons
Set size
Mutated donor sites 67 42
Mutated acceptor sites 42 72
All 109 114 154846
Exon length (nucleotides)
Mutated donor sites 114 147 0,024
Mutated acceptor sites 112,5 130 n/s
All 114 136 0,020 123
Densities of cis-acting elements(candidate sites per nucleotide)
ESEfinder: SC35
Mutated donor sites 0,043 0,042 n/s
Mutated acceptor sites 0,038 0,045 n/s
All 0,042 0,043 n/s 0,038
ESEfinder: SF2/ASF
Mutated donor sites 0,025 0,037 0,048
Mutated acceptor sites 0,036 0,041 n/s
All 0,028 0,040 0,005 0,036
ESEfinder: SRp40
Mutated donor sites 0,034 0,043 0,006
Mutated acceptor sites 0,040 0,043 n/s
All 0,035 0,043 0,004 0,040
ESEfinder: SRp55
Mutated donor sites 0,028 0,024 n/s
Mutated acceptor sites 0,022 0,023 n/s
All 0,025 0,023 n/s 0,023
RESCUE-ESE
Mutated donor sites 0,090 0,108 n/s
Mutated acceptor sites 0,100 0,080 n/s
All 0,091 0,094 n/s 0,099
PESE
Mutated donor sites 0,048 0,082 0,007
Mutated acceptor sites 0,057 0,055 n/s
All 0,055 0,064 0,023 0,064
PESS
Mutated donor sites 0,012 0,008 n/s
Mutated acceptor sites 0,009 0,007 n/s
All 0,011 0,007 n/s 0,007
Splice site scores
Mutated donor sites
Authentic donor sites 18,52 18,49 n/s 18,82
Acceptor sites of the (upstream) exon 18,70 19,67 n/s 19,08
Acceptor sites of the (downstream) intron 19,37 18,98 n/s 19,09
Mutated acceptor sites
Authentic acceptor sites 19,59 18,72 0,05 19,08
Donor sites of the (downstream) exon 18,44 18,56 n/s 18,82
Donor sites of the (upstream) intron 18,48 18,51 n/s 18,79
Distance to the closest candidate site(nucleotides)
Mutated donor sites 220,5 75 0,067 289
Mutated acceptor sites 185 66 0,024 81BMC Genomics 2008, 9:13 http://www.biomedcentral.com/1471-2164/9/13
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tional alternative splice sites are weaker than constitutive
splice sites [41,42]. Further, longer introns in general tend
to have stronger splice sites; however, the latter trend
becomes observable only for bona fide introns longer
than 1500 nt [43], and thus should not influence the
majority of retained introns studies here.
It has been demonstrated that both human and plant
retained introns are more prevalent in the 5'- and espe-
cially 3'-untranslated regions, compared to the protein-
coding regions of the mRNAs mechanism [8,10]. This has
been ascribed to elimination of abnormally spliced
mRNAs by the NMD mechanism [44]. However, this
would not explain the observed prevalence of NMD-
inducing retained introns in the 5'-regions. Our results
demonstrate monotonic increase in the fraction of mostly
retained introns in the 5'-to-3' direction. This is consistent
with some degree of co-transciptional splicing (as
opposed to simple commitment to splicing with the
actual process starting simultaneously for all intron)
observed in experiment [45]. However, this correlation is
not straightforward. Indeed, since we considered only
introns bounded on both sides by internal exons, and
required that the boundaries of the exon containing the
unspliced intron coincided exactly with the boundaries of
the corresponding exon-intron-exon chain in the RefSeq
mRNA isoform (see Methods), all retained introns consid-
ered here are followed by spliced out introns. This means
that the observed tendency may not be a simple conse-
quence of completely unspliced 3'-termini.
The observed differences in the density of exonic splicing
enhancers in the retained and constitutive introns as well
as in the C-exons and S-exons also seem to have a natural
biological interpretation. Indeed, a high density of ESE-
like sites in an (relatively short) intron may lead to misrec-
ognition of this intron as a part of an exon together with
the flanking exons. Similarly, a high density of ESEs in an
exon with a mutated site may force the splicing machinery
to retain this exon and use a cryptic site, whereas ESSs
might provoke skipping the exon. A puzzling observation
that candidate enhancers predicted by RESCUE-ESE were
more abundant in the constitutively splice introns than in
retained ones may be explained by the fact that this
method, unlike PESX, is based on the comparison of oli-
gonucleotide frequencies in constitutive and alternative
exons and does not control for the distribution of these
oligonucleotides in introns [35-37]. A similar observation
was recently made in [33]. Another coincidence between
our study and [33] is that not all SELEX-based ESEFinder
candidate exonic splicing enhancers have different densi-
ties in the S-exons and C-exons: in [33], the most pro-
nounced effect was observed for SF2/ASF, whereas in our
study a more statistically significant difference was seen
for SRp40. In retained introns, the most prevalent candi-
date splicing enhancers were those for SF2/ASF and SC35,
trailed by those for SRp40 and, marginally significant, for
SRp55.
Unfortunately, at present it seems impossible to repeat
these analyses with intronic splicing enhancers and silenc-
ers, since no programs for their recognition are available.
A more convoluted, but still plausible explanation may be
found for the observed significant difference in the
strength of authentic acceptor sites of the C-exons and S-
exons: an exon with a weak splice site already contains
more splicing enhancers than an exon with strong sites
[35,46,47], and thus it is more likely to become a C-exon
if the site is disrupted by a mutation.
Conclusion
Thus the analysis of retained introns in human cDNA,
exons skipped due to mutations in splice sites and exons
with cryptic sites produced results consistent with the
intron definition mechanism of splicing of short introns
and the model of co-transcriptional splicing. Retained
introns tend to be short and contain a higher density of
splicing enhancers. Skipped exons contain more candi-
date splicing enhancers and less silencers, compared to
exons with activated cryptic sites. Skipped exons also do
not have strong candidate splice sites in the vicinity of
mutated ones.
Methods
Set of RefSeq scaffolds
Human genome (version 18, March 2006) and align-
ments of RefSeq genes (21.02.07) and high-throughput
cDNAs (16.06.07) were downloaded from the UCSC
genome browser [48]; the EST data were not used. Initially
the dataset contained 25388 RefSeq mRNAs. Isoforms of
alternatively spliced genes were clustered by the RefSeq
gene name. To avoid redundancy in the structures of alter-
natively spliced genes, only the longest isoform for each
such gene was retained and used as the scaffold in all fur-
ther calculations. Isoform lengths were calculated for
spliced mRNAs. The final set of RefSeq genes consisted of
18458 genes containing 154846 internal exons and
138777 introns between such exons. All measurements
and comparisons of internal exons and introns were made
according to the accepted scaffold gene structures and, in
the case of mutated exons, for authentic sequences.
Sets of mutated exons
Sets of mutated exons included only internal exons
affected by single-nucleotide substitutions in splice sites
(from -3 to +6 for donor sites and from -15 to +2 for
acceptor sites) leading to the exon-skipping (S-exons) or
cryptic site activation (C-exons). The set of C-exon was
also restricted to cryptic sites located in exons and introns
adjacent to the mutated site. The set of C-exons withBMC Genomics 2008, 9:13 http://www.biomedcentral.com/1471-2164/9/13
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mutations in donor splice sites was obtained from [40],
and contained 42 exons. The set of C-exons with muta-
tions in acceptor sites was obtained from the DBASS3
database [39] and contained 72 exons. The set of S-exons
was collected by search of published examples of exon
skipping in OMIM [49] and PubMed. The collected S
exons were identified in the set of RefSeq scaffolds. The
final set contained, respectively, 67 and 42 S-exons with
mutations in donor and acceptor sites. The sets of donor
and acceptor S-exons are available as Additional files 1
and 2 respectively.
Sets of retained and constitutive (constitutively spliced 
out) introns
An intron retention event was scored if the high-through-
put cDNA sequencing data contained an exon that exactly
covered an exon-intron-exon chain in a RefSeq gene (Fig.
1). Such intron was called a retained intron. All other
introns were considered to be constitutive introns. Since
parameters of flanking exons were analyzed, only introns
between internal exons from the RefSeq scaffolds were
considered. The final set consisted of 1197 retained and
137580 constitutive introns.
Splice site scores
Scores of the donor and acceptor splicing sites were calcu-
lated using positional weight matrices covering positions
from -3 to +6 (for donor sites) and from -15 to +2 (for
acceptor sites). The positional nucleotide weights were
calculated as in [50]: W(b,m) = log [N(b,m)+0.5]-
0.25·Σi=A,C,G,T  log [N(i,m)+0.5] where N(b,m) is the
count of nucleotide b in position m in the training sam-
ple. The training sample was obtained from the EDAS
database [6], and contained 4179 constitutive internal
exons confirmed by at least 50 EST. The score of a donor
site (b-3,...,b6), where bj are nucleotides, was then calcu-
lated as a sum of positional weights: S(b-3,...,b6) = W(b-3,-
3)+...+W(b6,6), and similarly for scores of acceptor sites.
Densities of cis-acting elements
Putative cis-regulatory elements were identified in all
internal exons and introns by several published methods.
In particular, we searched for ESE motifs initially identi-
fied by SELEX (SF2/ASF, SC35, SRp40, SRp55) using ESE-
finder [34]; 238 ESE hexamers predicted by RESCUE-ESE
[35]; and 2060 ESE and 1018 ESS octamers predicted by
PESX [36,37]. The densities of predicted regulatory ele-
ments were defined as the number of candidate of ESE
sand ESS per base pair.
Statistical analysis
The statistical significance of differences between distribu-
tions of all intron parameters was measured by the Two
sample Kolmogorov-Smirnov test and Student's t-test. The
only exception was the distributions of the intron ordinal
number, where we used the χ2 test instead of the Kol-
mogorov-Smirnov test. The significance of differences
between mutated exon parameters, due to small data set
size was measured by the Mann-Whitney test. All these
tests were implemented in the R-Package [51].
Authors' contributions
MSG conceived the project. EZK collected and analyzed
the data. MSG and EZK wrote the manuscript.
Additional material
Acknowledgements
We are grateful to Ramil Nurdtinov and Andrei Mironov for useful discus-
sions. This study was partially supported by grants from the Howard 
Hughes Medical Institute (55001056), INTAS (05-8028), Russian Academy 
of Sciences (program "Cellular and Molecular Biology"), and the Russian 
Foundation of Basic Research (07-04-00343).
References
1. Berget SM: Exon recognition in vertebrate splicing.  J Biol Chem
1995, 270:2411-2414.
2. Ast G: How did alternative splicing evolve?  Nat Rev Genet 2004,
5:773-782.
3. Krawczak M, Thomas NS, Hundrieser B, Mort M, Wittig M, Hampe J,
Cooper DN: Single base-pair substitutions in exon-intron
junctions of human genes: nature, distribution, and conse-
quences for mRNA splicing.  Hum Mutat 2007, 28:150-158.
4. Nakai K, Sakamoto H: Construction of a novel database con-
taining aberrant splicing mutations of mammalian genes.
Gene 1994, 141:171-177.
5. Kim E, Magen A, Ast G: Different levels of alternative splicing
among eukaryotes.  Nucleic Acids Res 2007, 35:125-131.
6. Nurtdinov RN, Neverov AD, Mal'ko DB, Kosmodem'ianskii IA, Erma-
kova EO, Ramenskii VE, Mironov AA, Gel'fand MS: EDAS, data-
bases of alternatively spliced human genes.  Biofizika 2006,
51:589-592.
7. Wang BB, Brendel V: Genome-wide comparative analysis of
alternative splicing in plants.  Proc Natl Acad Sci USA 2006,
103:7175-7180.
8. Galante PA, Sakabe NJ, Kirschbaum-Slager N, de Souza SJ: Detection
and evaluation of intron retention events in the human tran-
scriptome.  RNA 2004, 10:757-765.
9. Sakabe NJ, de Souza SJ: Sequence features responsible for
intron retention in human.  BMC Genomics 2007, 8:59.
Additional file 1
List of skipped exons (S-exons) with mutations in donor sites. List of 
skipped exons (S-exons) with mutated donor sites: gene name, ordinal 
number of the skipped exon in the gene, exon sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-13-S1.txt]
Additional file 2
List of skipped exons (S-exons) with mutations in acceptor sites. List of 
skipped exons (S-exons) with mutated acceptor sites: gene name, ordinal 
number of the skipped exon in the gene, exon sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-13-S2.txt]BMC Genomics 2008, 9:13 http://www.biomedcentral.com/1471-2164/9/13
Page 10 of 10
(page number not for citation purposes)
10. Ner-Gaon H, Fluhr R: Whole-genome microarray in Arabidop-
sis facilitates global analysis of retained introns.  DNA Res 2006,
13:111-21.
11. Hiller M, Huse K, Platzer M, Backofen R: Non-EST based predic-
tion of exon skipping and intron retention events using Pfam
information.  Nucleic Acids Res 2005, 33:5611-5621.
12. Kienzle N, Young DB, Liaskou D, Buck M, Greco S, Sculley TB:
Intron retention may regulate expression of Epstein-Barr
virus nuclear antigen 3 family genes.  J Virol 1999, 73:1195-1204.
13. Chao C, Ives KL, Goluszko E, Kolokoltsov AA, Davey RA, Townsend
CM Jr, Hellmich MR: SRC regulates constitutive internalization
and rapid resensitization of a cholecystokinin 2 receptor
splice variant.  J Biol Chem 2005, 280:33368-33373.
14. Tai HH, Williams M, Iyengar A, Yeates J, Beardmore T: Regulation
of the beta-hydroxyacyl ACP dehydratase gene of Picea
mariana by alternative splicing.  Plant Cell Rep 2007, 26:105-113.
15. Li Y, Bor YC, Misawa Y, Xue Y, Rekosh D, Hammarskjold ML: An
intron with a constitutive transport element is retained in a
Tap messenger.  Nature 2006, 443:234-237.
16. Lejeune F, Cavaloc Y, Stevenin J: Alternative splicing of intron 3
of the serine/arginine-rich protein 9G8 gene. Identification of
flanking exonic splicing enhancers and involvement of 9G8 as
a trans-acting factor.  J Biol Chem 2001, 276:7850-7858.
17. Rio DC: Regulation of Drosophila P-element transposition.
Trends Genet 1991, 7:282-287.
18. Pampori NA, Shapiro BH: Nominal growth hormone pulses in
otherwise normal masculine plasma profiles induce intron
retention of overexpressed hepatic CYP2C11 with associ-
ated nuclear splicing deficiency.  Endocrinology 2000,
141:4100-4106.
19. Tan OL, Whitbread AK, Clements JA, Dong Y: Kallikrein-related
peptidase (KLK) family mRNA variants and protein isoforms
in hormone-related cancers: do they have a function?  Biol
Chem 2006, 387:697-705.
20. Michael IP, Kurlender L, Memari N, Yousef GM, Du D, Grass L,
Stephan C, Jung K, Diamandis EP: Intron retention: a common
splicing event within the human kallikrein gene family.  Clin
Chem 2005, 51:506-15.
21. Blanco E, Rojas R, Haeger P, Cuevas R, Perez C, Munita R, Quiroz G,
Andres ME, Forray MI, Gysling K: Intron retention as an alterna-
tive splice variant of the rat urocortin 1 gene.  Neuroscience
2006, 140:1245-1252.
22. Shaftel SS, Olschowka JA, Hurley SD, Moore AH, O'Banion MK:
COX-3: a splice variant of cyclooxygenase-1 in mouse neural
tissue and cells.  Brain Res Mol Brain Res 2003, 119:213-215.
23. Dai R, Bergson C: Structure and expression of the murine cal-
cyon gene.  Gene 2003, 311:111-117.
24. Melhuish TA, Wotton D: The Tgif2 gene contains a retained
intron within the coding sequence.  BMC Mol Biol 2006, 7:2.
25. Malko DB, Makeev VJ, Mironov AA, Gelfand MS: Evolution of exon-
intron structure and alternative splicing in fruit flies and
malarial mosquito genomes.  Genome Res 2006, 16:505-509.
26. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S,
Nikaido I, Osato N, Saito R, Suzuki H, Yamanaka I, Kiyosawa H, Yagi
K, Tomaru Y, Hasegawa Y, Nogami A, Schönbach C, Gojobori T,
Baldarelli R, Hill DP, Bult C, Hume DA, Quackenbush J, Schriml LM,
Kanapin A, Matsuda H, Batalov S, Beisel KW, Blake JA, Bradt D, FAN-
TOM consortium; RIKEN Genome Exploration Research Group
Phase I & II Team: Analysis of the mouse transcriptome based
on functional annotation of 60,770 full-length cDNAs.  Nature
2002, 420:563-573.
27. Sakabe NJ, de Souza JE, Galante PA, de Oliveira PS, Passetti F, Bren-
tani H, Osorio EC, Zaiats AC, Leerkes MR, Kitajima JP, Brentani RR,
Strausberg RL, Simpson AJ, de Souza SJ: ORESTES are enriched in
rare exon usage variants affecting the encoded proteins.  C R
Biol 2003, 326:979-985.
28. Carothers AM, Urlaub G, Grunberger D, Chasin LA: Splicing
mutants and their second-site suppressors at the dihydro-
folate reductase locus in Chinese hamster ovary cells.  Mol
Cell Biol 1993, 13:5085-5098.
29. O'Neill JP, Rogan PK, Cariello N, Nicklas JA: Mutations that alter
RNA splicing of the human HPRT gene: a review of the spec-
trum.  Mutat Res 1998, 411:179-214.
30. Iida Y: A mechanism for unsplicing and exon skipping in
human alpha- and beta-globin mutant pre-mRNA splicing.
Nucleic Acids Symp Ser 1997, 37:183-184.
31. Wimmer K, Roca X, Beiglbock H, Callens T, Etzler J, Rao AR, Krainer
AR, Fonatsch C, Messiaen L: Extensive in silico analysis of NF1
splicing defects uncovers determinants for splicing outcome
upon 5' splice-site disruption.  Hum Mutat 2007, 28:599-612.
32. Kralovicová J, Christensen MB, Voøechovský I: Biased exon/intron
distribution of cryptic and de novo 3' splice sites.  Nucleic Acids
Res 2005, 33:4882-4898.
33. Kralovicová J, Voøechovský I: Global control of aberrant splice-
site activation by auxiliary splicing sequences: evidence for a
gradient in exon and intron definition.  Nucleic Acids Res .
Advance access publication September 18, 2007
34. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR: ESEfinder: A
web resource to identify exonic splicing enhancers.  Nucleic
Acids Res 2003, 31:3568-3571.
35. Fairbrother WG, Yeh RF, Sharp PA, Burge CB: Predictive identifi-
cation of exonic splicing enhancers in human genes.  Science
2002, 297:1007-1013.
36. Zhang XH, Chasin LA: Computational definition of sequence
motifs governing constitutive exon splicing.  Genes Dev 2004,
18:1241-1250.
37. Zhang XH, Kangsamaksin T, Chao MS, Banerjee JK, Chasin LA: Exon
inclusion is dependent on predictable exonic splicing enhanc-
ers.  Mol Cell Biol 2005, 25:7323-7332.
38. Hawkins JD: A survey on intron and exon lengths.  Nucleic Acids
Res 1988, 16:9893-9908.
39. Voøechovský I: Aberrant 3' splice sites in human disease
genes: mutation pattern, nucleotide structure and compari-
son of computational tools that predict their utilization.
Nucleic Acids Res 2006, 34:4630-4641.
40. Roca X, Sachidanandam R, Krainer AR: Intrinsic differences
between authentic and cryptic 5' splice sites.  Nucleic Acids Res
2003, 31:6321-6333.
41. Yeo GW, Van Nostrand E, Holste D, Poggio T, Burge CB: Identifi-
cation and analysis of alternative splicing events conserved in
human and mouse.  Proc Natl Acad Sci USA 2005, 102:2850-2855.
42. Clark F, Thanaraj TA: Categorization and characterization of
transcript confirmed constitutively and alternatively spliced
introns and exons from human.  Hum Mol Genet 2002,
11:451-464.
43. Dewey CN, Rogozin IB, Koonin EV: Compensatory relationship
between splice sites and exonic splicing signals depending on
the length of vertebrate introns.  BMC Genomics 2006, 7:311.
44. Lewis BP, Green RE, Brenner SE: Evidence for the widespread
coupling of alternative splicing and nonsense-mediated
mRNA decay in humans.  Proc Natl Acad Sci USA 2003,
100:189-192.
45. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G: Mul-
tiple links between transcription and splicing.  RNA 2004,
10:1489-1498.
46. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB: System-
atic identification and analysis of exonic splicing silencers.
Cell 2004, 119:831-845.
47. Wang Z, Xiao X, Van Nostrand E, Burge CB: General and specific
functions of exonic splicing silencers in splicing control.  Mol
Cell 2006, 23:61-70.
48. UCSC Genome Browser   [http://genome.ucsc.edu]
49. Online Mendelian Inheritance in Man, OMIM   [http://
www.ncbi.nlm.nih.gov/omim/]
50. Gelfand MS, Koonin EV, Mironov AA: Prediction of transcription
regulatory sites in Archaea by a comparative genomic
approach.  Nucleic Acids Res 2000, 28:695-705.
51. The R Project for Statistical Computing   [http://www.r-
project.org/]